For more information or confidential assistance
Call 800-306-3180

Takeda Offers $2.2 Billion Actos Settlement

Actos
Takeda Pharmaceuticals, manufacturer of Actos, is willing to pay $2.2 billion to resolve claims that it concealed cancer risks linked to its diabetes medicine. The proposed Actos settlement, if accepted by plaintiffs, would mark one of the largest U.S. accords of patient lawsuits involving pharmaceutical... Read More